Imagion Biosystems Ltd. ( (AU:IBX) ) just unveiled an announcement.
Imagion Biosystems Ltd. announced the application for the quotation of 75,000,000 new securities on the ASX, with options expiring on December 13, 2027, at an exercise price of $0.04. This move is likely to impact the company’s financial structure and market presence, potentially offering new opportunities for investment and growth within the biotechnology sector.
More about Imagion Biosystems Ltd.
Imagion Biosystems Ltd. operates in the biotechnology industry, focusing on the development of advanced diagnostic imaging technologies. The company is known for its innovative approach to medical imaging, particularly in the detection and diagnosis of cancer.
YTD Price Performance: -39.13%
Average Trading Volume: 1,012,405
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$2.82M
Find detailed analytics on IBX stock on TipRanks’ Stock Analysis page.